Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy NeuroBo Pharmaceuticals (NRBO) stock
Learn how to easily invest in NeuroBo Pharmaceuticals stock.
NeuroBo Pharmaceuticals, Inc is a biotechnology business based in the US. NeuroBo Pharmaceuticals shares (NRBO) are listed on the NASDAQ and all prices are listed in US Dollars. NeuroBo Pharmaceuticals employs 7 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in NeuroBo Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NRBO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
NeuroBo Pharmaceuticals stock price (NASDAQ: NRBO)Use our graph to track the performance of NRBO stocks over time.
NeuroBo Pharmaceuticals shares at a glance
|Latest market close||$2.82|
|52-week range||$2.70 - $7.61|
|50-day moving average||$3.16|
|200-day moving average||$4.07|
|Wall St. target price||$16.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-19.93|
Buy NeuroBo Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NeuroBo Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NeuroBo Pharmaceuticals price performance over time
|1 week (2021-07-12)||N/A|
|1 month (2021-06-23)||-12.15%|
|3 months (2021-04-19)||N/A|
|6 months (2021-01-19)||N/A|
|1 year (2020-07-19)||N/A|
|2 years (2019-07-19)||N/A|
|3 years (2018-07-19)||N/A|
|5 years (2016-07-19)||N/A|
NeuroBo Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-53.31%|
|Return on equity TTM||-270.66%|
|Market capitalisation||$72.2 million|
TTM: trailing 12 months
Shorting NeuroBo Pharmaceuticals shares
There are currently 226,430 NeuroBo Pharmaceuticals shares held short by investors – that's known as NeuroBo Pharmaceuticals's "short interest". This figure is 52.8% down from 479,343 last month.
There are a few different ways that this level of interest in shorting NeuroBo Pharmaceuticals shares can be evaluated.
NeuroBo Pharmaceuticals's "short interest ratio" (SIR)
NeuroBo Pharmaceuticals's "short interest ratio" (SIR) is the quantity of NeuroBo Pharmaceuticals shares currently shorted divided by the average quantity of NeuroBo Pharmaceuticals shares traded daily (recently around 595868.42105263). NeuroBo Pharmaceuticals's SIR currently stands at 0.38. In other words for every 100,000 NeuroBo Pharmaceuticals shares traded daily on the market, roughly 380 shares are currently held short.
However NeuroBo Pharmaceuticals's short interest can also be evaluated against the total number of NeuroBo Pharmaceuticals shares, or, against the total number of tradable NeuroBo Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NeuroBo Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 NeuroBo Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0357% of the tradable shares (for every 100,000 tradable NeuroBo Pharmaceuticals shares, roughly 36 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NeuroBo Pharmaceuticals.
Find out more about how you can short NeuroBo Pharmaceuticals stock.
NeuroBo Pharmaceuticals share dividends
We're not expecting NeuroBo Pharmaceuticals to pay a dividend over the next 12 months.
Have NeuroBo Pharmaceuticals's shares ever split?
NeuroBo Pharmaceuticals's shares were split on a 1:25 basis on 30 December 2019. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeuroBo Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NeuroBo Pharmaceuticals shares which in turn could have impacted NeuroBo Pharmaceuticals's share price.
NeuroBo Pharmaceuticals overview
NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts. .
Stocks similar to NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals in the news
61 Biggest Movers From Yesterday
38 Stocks Moving In Wednesday's Mid-Day Session
Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views
Frequently asked questionsWhat percentage of NeuroBo Pharmaceuticals is owned by insiders or institutions?
Currently 38.406% of NeuroBo Pharmaceuticals shares are held by insiders and 39.657% by institutions. How many people work for NeuroBo Pharmaceuticals?
Latest data suggests 7 work at NeuroBo Pharmaceuticals. When does the fiscal year end for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals's fiscal year ends in December. Where is NeuroBo Pharmaceuticals based?
NeuroBo Pharmaceuticals's address is: 200 Berkeley Street, Boston, MA, United States, 02116 What is NeuroBo Pharmaceuticals's ISIN number?
NeuroBo Pharmaceuticals's international securities identification number is: US64132R1077 What is NeuroBo Pharmaceuticals's CUSIP number?
NeuroBo Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 36870A108
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert